首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

2008148

動物結核病疫苗市場：按類型、給藥途徑、目標動物和地區分類

Veterinary Tuberculosis Vaccine Market, By Type, By Route of Administration, By Animal Type, By Geography

出版日期: 2026年03月26日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年動物結核病疫苗市場規模估計為5,700萬美元，預計2033年將達7,100萬美元。預計2026年至2033年，該市場將以3.2%的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	5700萬美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	3.20%	預計金額（2033 年）	7100萬美元

結核病（TB）是由分枝桿菌屬細菌引起的動物和人類性行為感染傳染病，屬於肉芽腫性疾病。結核病通常被認為是一種慢性且致殘性疾病，但有時也會呈現急性且快速進展的病程。幾乎所有脊椎動物都可能感染結核病。結核分枝桿菌（M. tuberculosis）多重抗藥性（MDR）和廣譜抗藥性（XDR）菌株的廣泛出現，令臨床醫生、公共衛生部門和監管機構對控制疾病感到擔憂。牛結核病在世界非工業化國家仍然是重要的通用感染疾病。不同物種的症狀和病變通常相似。結核分枝桿菌複合群（哺乳動物結核病）的主要菌種包括結核分枝桿菌（M. tuberculosis）、卡內蒂分枝桿菌（M. canettii）、牛分枝桿菌（M. bovis）、山羊分枝桿菌（M. caprae）、海豹分枝桿菌（M. pinnipedii）、小鼠分枝桿菌（M. microtirica）。鳥分枝桿菌複合群包括鳥分枝桿菌（M. avium avium，禽結核菌）、人鳥分枝桿菌（M. avium hominissuis，從人類、豬和其他哺乳動物分離得到）和胞內分枝桿菌（M. intracellular）。

市場動態

預計疫苗相關臨床試驗的增加將推動全球動物結核病疫苗市場在預測期內成長。

例如，根據多學科數位出版研究所2020年6月發布的報告，獾正在接受肌肉注射卡介苗（丹麥）疫苗以預防結核病。報告也指出，山羊正在接受肌肉注射熱去活化牛分枝桿菌（HIMB）疫苗以預防結核病。

此外，政府部門加強對獸醫結核病的宣傳力度，預計將推動全球動物結核病疫苗市場在預測期內成長。

例如，2021年11月16日，英國政府宣布了一項結核病根除計畫。該計劃旨在英國進行結核病檢測，以進一步降低結核病傳播的風險。英國政府建議消費者在購買牛隻時充分了解相關信息，並披露待售牛隻的結核病情況。對於因結核病而被撲殺的牲畜，必須確保給予公平、適當且符合可用資金的補償。

本報告的主要特點

本報告指出了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本文根據以下參數，介紹了全球動物結核病疫苗市場主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球動物結核病疫苗市場》報告針對該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球動物結核病疫苗市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
南非
中非
北非

第8章競爭情勢

熱圖分析
市佔率分析
- Merck KGaA
- Colorado Serum Company
- CZ Vaccines（Zendal）
- Zoetis Inc.

第9章

分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI5242

Veterinary Tuberculosis Vaccine Market is estimated to be valued at USD 57 Mn in 2026 and is expected to reach USD 71 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 57 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	3.20%	2033 Value Projection:	USD 71 Mn

Tuberculosis (TB) is considered a reemerging, infectious granulomatous disease in animals and people caused by acid-fast bacilli of the genus Mycobacterium. Although commonly considered as a chronic, debilitating disease, TB occasionally assumes an acute, rapidly progressive course. The disease affects practically all species of vertebrates. The widespread occurrence of multidrug-resistant (MDR) strains and extensively drug-resistant (XDR) strains of M tuberculosis is of concern to clinicians and public health and regulatory officials involved in the control of the disease. Bovine TB is still a significant zoonosis in non-industrialized countries of the world. Signs and lesions are generally similar in the various species. The main types of M tuberculosis complex (mammalian tubercle bacilli) recognized are M tuberculosis, M canettii, M bovis, M caprae, M pinnipedii, M microti, M mungi, and M africanum. The M avium complex includes M avium avium (avian tubercle bacilli), M avium hominissuis (isolated from people, swine, and other mammals), and M intracellular.

Market Dynamics

Increasing undergoing trial for vaccination is expected to fuel growth of the global veterinary tuberculosis vaccine market over the forecast period.

For instance, according to a report published by Multidisciplinary Digital Publishing Institute in June 2020, BCG (Danish) vaccine type is administered by intramuscular to badgers for the prevention of tuberculosis. According to the same source, heat-inactivated Mycobacterium bovis vaccine (HIMB) is administered by intramuscular method to goats for the prevention of tuberculosis

Furthermore, increasing awareness programs for veterinary tuberculosis by government authorities is expected to drive growth of the global veterinary tuberculosis vaccine market over the forecast period.

For instance, on November 16, 2021, The Welsh Government, U.K. announced the Tuberculosis (TB) Eradication Programme. This program's goal was to offer a TB testing programme in Wales, U.K., in order to further lower the danger of the spread of TB. The Welsh Government, U.K. has advised to make informed purchase selections and to disclose TB information about any cattle they seek to sell. Payments for animals that were killed due to TB, to make sure the method is just and appropriate and takes into account the available funding.

Key features of the study

This report provides an in-depth analysis of the global veterinary tuberculosis vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global veterinary tuberculosis vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck KGaA, Colorado Serum Company, CZ Vaccines (Zendal), and Zoetis Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global veterinary tuberculosis vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary tuberculosis vaccine market

Market Segmentation

By Type
- Live Attenuated
- Inactivated
By Route of Administration
- Sub-cutaneous
- Intramuscular
- Oral
By Animal Type
- Cattle
- Dogs
- Cats
- Others
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players
- Merck KGaA
- Colorado Serum Company
- CZ Vaccines (Zendal)
- Zoetis Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Animal Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Key Developments
Industry Trends
Regulatory Scenario
Recent Product Approval/Launches
PEST Analysis
Porter's Analysis

4. Global Veterinary Tuberculosis Vaccine Market, By Type, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Live Attenuated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Inactivated
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Veterinary Tuberculosis Vaccine Market, By Route of Administration, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Sub-cutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Veterinary Tuberculosis Vaccine Market, By Animal Type, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Dogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
Cats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global Veterinary Tuberculosis Vaccine Market, By Region, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033(%)
- Y-o-Y Growth Analysis, For Regions, 2026 - 2033
- Regional Trends
North America
- Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Animal Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Region/Country, 2026 - 2033 (USD Mn)
South Africa
Central Africa
North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Colorado Serum Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- CZ Vaccines (Zendal)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Zoetis Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
  - Analyst Views